Curaleaf Holdings (CURLF) Consolidated Net Income (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Consolidated Net Income of -$293000.0 in Q1 2026, up 100.0% quarter-over-quarter from -$8.3 billion in Q4 2025, and up 97.13% on a YoY basis from -$148636.3 in Q1 2025.
Curaleaf Holdings (CURLF) Consolidated Net Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Consolidated Net Income history runs 8 years deep, the most recent figure standing at -$293000.0 for Q1 2026.
- In Q1 2026, Consolidated Net Income rose 97.13% year-over-year to -$293000.0; the TTM figure through Mar 2026 stood at -$11.3 billion (down 53224.66% YoY), while the FY2025 annual figure was -$26.2 million, down 152.45% from the prior year.
- Consolidated Net Income was -$293000.0 for Q1 2026 at Curaleaf Holdings, up from -$8.3 billion in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $21.4 million in Q1 2022 to a low of -$8.3 billion in Q4 2025.
- Historically, Consolidated Net Income has averaged -$1.1 billion across 5 years, with a median of -$10.2 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Consolidated Net Income soared 106.25% in 2024, then plunged 235138.84% in 2025.
- A 5-year view of Consolidated Net Income shows it stood at -$86.4 million in 2022, then slumped by 9157.22% to -$8.0 billion in 2023, then soared by 99.86% to -$11.3 million in 2024, then plunged by 73087.12% to -$8.3 billion in 2025, then jumped by 100.0% to -$293000.0 in 2026.
- The last three Consolidated Net Income figures came in at -$293000.0 (Q1 2026), -$8.3 billion (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -293,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -293,000.00 |
| Dec 31, 2025 | -8.28 Bn |
| Sep 30, 2025 | -2.14 Mn |
| Jun 30, 2025 | -3.00 Bn |
| Mar 31, 2025 | -10.19 Mn |
| Dec 31, 2024 | -11.31 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | 567,000.00 |
| Dec 31, 2023 | -8.00 Bn |
| Sep 30, 2023 | -25.92 Mn |
| Jun 30, 2023 | -7.90 Mn |
| Mar 31, 2023 | -12.59 Mn |
| Dec 31, 2022 | -86.37 Mn |
| Sep 30, 2022 | -12.73 Mn |
| Jun 30, 2022 | -4.50 Mn |
| Mar 31, 2022 | 21.39 Mn |
| Dec 31, 2021 | -5.24 Mn |
| Sep 30, 2021 | 62.95 Mn |
| Jun 30, 2021 | 76.97 Mn |